X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ADCOCK INGRAM
Jun-14
ORCHID PHARMA LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs194379-   
Low Rs35274-   
Sales per share (Unadj.) Rs276.5112.8-  
Earnings per share (Unadj.) Rs-79.2-28.4-  
Cash flow per share (Unadj.) Rs-43.5-23.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.988.5-  
Shares outstanding (eoy) m70.45168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.9 14.3%   
Avg P/E ratio x-1.4-11.5 12.6%  
P/CF ratio (eoy) x-2.6-13.9 19.0%  
Price / Book Value ratio x2.13.7 57.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,06755,082 14.6%   
No. of employees `0002.84.3 65.2%   
Total wages/salary Rs m2,5273,457 73.1%   
Avg. sales/employee Rs Th6,956.14,434.5 156.9%   
Avg. wages/employee Rs Th902.5805.3 112.1%   
Avg. net profit/employee Rs Th-1,993.0-1,117.4 178.4%   
INCOME DATA
Net Sales Rs m19,47719,037 102.3%  
Other income Rs m407133 305.4%   
Total revenues Rs m19,88419,171 103.7%   
Gross profit Rs m1,103-3,299 -33.4%  
Depreciation Rs m2,519822 306.6%   
Interest Rs m5,227516 1,013.6%   
Profit before tax Rs m-6,236-4,503 138.5%   
Minority Interest Rs m20-13 -156.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125281 -44.5%   
Profit after tax Rs m-5,580-4,797 116.3%  
Gross profit margin %5.7-17.3 -32.7%  
Effective tax rate %2.0-6.2 -32.1%   
Net profit margin %-28.7-25.2 113.7%  
BALANCE SHEET DATA
Current assets Rs m11,01413,943 79.0%   
Current liabilities Rs m32,0607,845 408.7%   
Net working cap to sales %-108.132.0 -337.3%  
Current ratio x0.31.8 19.3%  
Inventory Days Days95111 85.5%  
Debtors Days Days34124 27.1%  
Net fixed assets Rs m29,4408,127 362.2%   
Share capital Rs m70588 797.1%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,80014,942 25.4%   
Long term debt Rs m9,0185,251 171.7%   
Total assets Rs m46,51028,227 164.8%  
Interest coverage x-0.2-7.7 2.5%   
Debt to equity ratio x2.40.4 675.3%  
Sales to assets ratio x0.40.7 62.1%   
Return on assets %-0.8-15.2 5.0%  
Return on equity %-146.9-32.1 457.4%  
Return on capital %-3.7-19.8 18.9%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,6821,625 103.5%  
From Investments Rs m-9,860-499 1,976.3%  
From Financial Activity Rs m6,6444,766 139.4%  
Net Cashflow Rs m-1,5355,892 -26.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.23 Rs / ZAR

Compare ORCHID PHARMA LTD With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: VENUS REMEDIES  PLETHICO PHARMA  ABBOTT INDIA  SUN PHARMA  DR. DATSONS LABS  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jan 22, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS